Ivermectin; authorize pharmacists to provide to adults pursuant to collaborative pharmacy practice agreement.
Impact
The enactment of HB 1300 will significantly affect state laws concerning the role and authority of pharmacists. By allowing pharmacists to dispense ivermectin under specific conditions, the bill expands their responsibilities in patient care. It also introduces the possibility of charging administrative fees for these services in addition to dispensing costs, which could redefine the service offerings of pharmacies in the state. The bill also provides certain immunities for pharmacists and practitioners involved in dispensing ivermectin, protecting them from disciplinary actions unless gross negligence or willful misconduct is determined.
Summary
House Bill 1300 aims to authorize pharmacists in Mississippi to provide ivermectin to patients who are 18 years of age or older. This initiative is tied to the provisions of a collaborative pharmacy practice agreement that involves a valid, non-patient-specific prescriptive order. The bill mandates that standard procedures be established by the Board of Pharmacy, ensuring that pharmacists use a screening risk assessment tool and provide patients with a standardized factsheet about ivermectin, including its uses and contraindications. This step is seen as an effort to enhance patient education and safety in the use of this medication.
Contention
Some points of contention regarding HB 1300 arise from the broader implications of allowing pharmacists to provide ivermectin without a direct patient-specific prescription from physicians. Critics may argue that this could lead to misuse or misadvice regarding the drug's applications and effectiveness, especially given past controversies surrounding its use. Proponents, on the other hand, advocate for increased access to treatment options, emphasizing the importance of empowering pharmacists to enhance healthcare delivery for patients.
Expands the existing law regarding collaborative practice agreements between pharmacists and physicians to allow other healthcare providers to enter into such agreements and removes the definition of “collaborative practice committee.”